Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.
Open Access
- 1 March 1998
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 101 (5), 935-939
- https://doi.org/10.1172/jci2071
Abstract
A consistent phenotype observed in both human patients and several different mouse models of autosomal recessive polycystic kidney disease (ARPKD) is an increased activity of the epidermal growth factor receptor (EGFR) in the affected kidneys. To determine whether this increased activity of the EGFR is a functional event that is directly part of the disease pathway of renal cyst formation, we used a genetic approach to introduce a mutant EGFR with decreased tyrosine kinase activity into a murine model of ARPKD. We found that the modified form of the EGFR could block the increase in EGFR-specific tyrosine kinase activity that normally accompanies the development of renal cysts, and this correlated with an improvement in kidney function and a substantial decrease in cyst formation in the collecting ducts. These results suggest that changes in the expression of the EGFR contribute to the formation of cysts in the collecting ducts, and that drugs that target the tyrosine kinase activity of the EGFR may potentially be therapeutic in ARPKD.Keywords
This publication has 25 references indexed in Scilit:
- Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNAKidney International, 1996
- Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant PhenotypeScience, 1995
- Strain-Dependent Epithelial Defects in Mice Lacking the EGF ReceptorScience, 1995
- Tyrosine kinase activity of the EGF receptor in murine metanephric organ cultureKidney International, 1995
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidneyKidney International, 1995
- Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21–cenNature Genetics, 1994
- The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.Genes & Development, 1994
- Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidneyKidney International, 1991
- Defective epidermal growth factor gene expression in mice with polycystic kidney diseaseDevelopmental Biology, 1990
- Sodium-potassium ATPase activity mediates cyst formation in metanephric organ cultureKidney International, 1985